Share Price and Basic Stock Data
Last Updated: November 20, 2025, 10:22 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Family Care Hospitals Ltd operates in the Hospitals & Medical Services sector, with a current market capitalization of ₹20.8 Cr and a share price of ₹3.86. The company reported sales of ₹42.04 Cr for the fiscal year ending March 2023, which marked a slight decline from ₹42.07 Cr in the previous year. Revenue trends over the past quarters show fluctuations, with Q1 FY 2024 sales at ₹4.24 Cr, significantly lower than the ₹13.68 Cr reported in Q4 FY 2023. However, sales saw a rebound in Q2 FY 2024, reaching ₹12.43 Cr. Despite this, the trailing twelve months (TTM) sales stood at ₹0.14 Cr, indicating a challenging revenue environment. The reported sales figures demonstrate a volatile performance, which may raise concerns regarding the company’s ability to maintain consistent revenue generation.
Profitability and Efficiency Metrics
Family Care Hospitals Ltd’s profitability has been under pressure, as evidenced by a net profit of -₹6.42 Cr in the TTM. The company recorded a net profit of ₹5.26 Cr for FY 2023, which was an improvement from ₹5.20 Cr in FY 2022. However, the operating profit margin (OPM) stood at a staggering -1,900.00% for the trailing twelve months, reflecting significant operational inefficiencies. The company reported a return on equity (ROE) of 85.5% and a return on capital employed (ROCE) of 79.2%, both of which are notably high compared to industry norms. This indicates that while the company has the potential for high returns, its current profitability is hampered by operational challenges, as evidenced by the declining net profit and the negative OPM.
Balance Sheet Strength and Financial Ratios
The balance sheet of Family Care Hospitals Ltd appears to be relatively stable, with no reported borrowings and a debt-to-equity ratio of 0.25. This suggests a low level of financial leverage, which can be beneficial during periods of financial strain. The interest coverage ratio (ICR) was exceptionally high at 110.60x, indicating the company is well-positioned to meet its interest obligations. However, the book value per share reported at ₹2.49 for FY 2025 is substantially lower than the previous year’s ₹10.81, which raises concerns about asset valuation and shareholder equity. The current ratio of 1.28 indicates adequate short-term liquidity, but the quick ratio of 0.09 suggests potential difficulties in meeting immediate liabilities, highlighting a liquidity risk that could affect operational stability.
Shareholding Pattern and Investor Confidence
Family Care Hospitals Ltd has a diverse shareholding pattern, with promoters holding 18.54% of the equity, while public shareholders account for 81.37%. The presence of domestic institutional investors (DIIs) at 0.09% and the absence of foreign institutional investors (FIIs) may indicate a lack of confidence from larger institutional players. Over time, the number of shareholders has seen fluctuations, from 35,665 in December 2022 to 47,432 by September 2025. This increase in the number of shareholders may suggest growing interest from retail investors, although the low institutional ownership could reflect caution among more sophisticated investors regarding the company’s future prospects. The company’s ability to maintain or improve investor confidence will be crucial, especially in light of its recent financial performance.
Outlook, Risks, and Final Insight
Looking ahead, Family Care Hospitals Ltd faces significant challenges that could impact its operational and financial trajectory. The company’s declining sales and profitability metrics, coupled with a negative OPM, pose serious risks to its sustainability. Additionally, the substantial drop in book value per share and low quick ratio indicate potential liquidity issues that need addressing. However, the high ROCE and ICR suggest that the company has the inherent potential for strong returns if operational efficiencies can be improved. The lack of institutional support could hinder its ability to raise capital for necessary operational improvements. In conclusion, while there are strengths in the financial ratios, the company must navigate its operational challenges effectively to regain investor confidence and ensure long-term viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Family Care Hospitals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 46.5 Cr. | 139 | 195/125 | 9.49 | 117 | 2.52 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 21.2 Cr. | 20.2 | 35.5/18.3 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 12.6 Cr. | 12.2 | 21.4/11.6 | 140 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 121 Cr. | 64.6 | 98.7/52.3 | 26.7 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 20.8 Cr. | 3.86 | 7.60/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 28,109.86 Cr | 846.56 | 102.82 | 102.21 | 0.27% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.24 | 11.35 | 11.02 | 13.68 | 11.93 | 12.43 | 11.40 | 4.24 | 3.97 | 3.88 | 0.03 | 0.02 | 0.02 |
| Expenses | 9.23 | 9.19 | 9.05 | 11.48 | 9.66 | 10.42 | 9.91 | 3.27 | 3.74 | -27.09 | 1.78 | 1.06 | 0.40 |
| Operating Profit | 2.01 | 2.16 | 1.97 | 2.20 | 2.27 | 2.01 | 1.49 | 0.97 | 0.23 | 30.97 | -1.75 | -1.04 | -0.38 |
| OPM % | 17.88% | 19.03% | 17.88% | 16.08% | 19.03% | 16.17% | 13.07% | 22.88% | 5.79% | 798.20% | -5,833.33% | -5,200.00% | -1,900.00% |
| Other Income | 0.24 | 0.28 | 0.14 | 0.33 | 0.27 | 0.26 | 0.57 | 2.08 | 0.48 | -73.97 | 0.00 | 2.03 | 0.00 |
| Interest | 0.12 | 0.11 | 0.14 | 0.12 | 0.29 | 0.15 | 0.09 | 0.09 | 0.09 | 0.06 | 0.07 | 0.07 | 0.08 |
| Depreciation | 0.37 | 0.35 | 0.36 | 0.33 | 0.36 | 0.36 | 0.36 | 0.34 | 0.32 | 0.28 | 0.28 | 0.25 | 0.23 |
| Profit before tax | 1.76 | 1.98 | 1.61 | 2.08 | 1.89 | 1.76 | 1.61 | 2.62 | 0.30 | -43.34 | -2.10 | 0.67 | -0.69 |
| Tax % | 26.14% | 25.76% | 26.09% | 37.02% | 29.10% | 28.41% | 30.43% | -227.48% | 26.67% | -0.18% | 0.00% | -47.76% | 0.00% |
| Net Profit | 1.30 | 1.46 | 1.19 | 1.30 | 1.34 | 1.26 | 1.12 | 8.58 | 0.23 | -43.27 | -2.10 | 0.99 | -0.70 |
| EPS in Rs | 0.18 | 0.20 | 0.16 | 0.24 | 0.25 | 0.23 | 0.21 | 1.59 | 0.04 | -8.01 | -0.39 | 0.18 | -0.13 |
Last Updated: August 19, 2025, 3:45 pm
Below is a detailed analysis of the quarterly data for Family Care Hospitals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Expenses, as of Jun 2025, the value is 0.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.06 Cr. (Mar 2025) to 0.40 Cr., marking a decrease of 0.66 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.38 Cr.. The value appears strong and on an upward trend. It has increased from -1.04 Cr. (Mar 2025) to -0.38 Cr., marking an increase of 0.66 Cr..
- For OPM %, as of Jun 2025, the value is -1,900.00%. The value appears strong and on an upward trend. It has increased from -5,200.00% (Mar 2025) to -1,900.00%, marking an increase of 3,300.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 2.03 Cr..
- For Interest, as of Jun 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.08 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.25 Cr. (Mar 2025) to 0.23 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.69 Cr.. The value appears to be declining and may need further review. It has decreased from 0.67 Cr. (Mar 2025) to -0.69 Cr., marking a decrease of 1.36 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -47.76% (Mar 2025) to 0.00%, marking an increase of 47.76%.
- For Net Profit, as of Jun 2025, the value is -0.70 Cr.. The value appears to be declining and may need further review. It has decreased from 0.99 Cr. (Mar 2025) to -0.70 Cr., marking a decrease of 1.69 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.13. The value appears to be declining and may need further review. It has decreased from 0.18 (Mar 2025) to -0.13, marking a decrease of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.01 | 0.07 | 1.07 | 1.80 | 5.19 | 14.19 | 13.25 | 35.36 | 42.07 | 42.04 | 40.01 | 7.90 | 0.14 |
| Expenses | 0.35 | 0.24 | 0.86 | 1.54 | 3.84 | 12.73 | 10.98 | 27.18 | 33.37 | 33.59 | 33.12 | -21.33 | 7.69 |
| Operating Profit | -0.34 | -0.17 | 0.21 | 0.26 | 1.35 | 1.46 | 2.27 | 8.18 | 8.70 | 8.45 | 6.89 | 29.23 | -7.55 |
| OPM % | -3,400.00% | -242.86% | 19.63% | 14.44% | 26.01% | 10.29% | 17.13% | 23.13% | 20.68% | 20.10% | 17.22% | 370.00% | -5,392.86% |
| Other Income | 0.00 | -24.63 | 0.20 | 0.19 | 0.24 | 0.04 | -0.12 | -0.28 | 0.30 | 0.98 | 3.19 | -71.71 | 2.13 |
| Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.12 | 0.51 | 0.84 | 0.83 | 0.50 | 0.60 | 0.53 | 0.86 | 0.32 |
| Depreciation | 0.00 | 0.03 | 0.38 | 0.25 | 0.39 | 0.94 | 1.28 | 1.42 | 1.44 | 1.41 | 1.42 | 1.13 | 0.99 |
| Profit before tax | -0.34 | -24.83 | 0.02 | 0.19 | 1.08 | 0.05 | 0.03 | 5.65 | 7.06 | 7.42 | 8.13 | -44.47 | -6.73 |
| Tax % | 0.00% | 0.00% | 0.00% | 21.05% | 20.37% | 60.00% | 33.33% | 27.96% | 26.35% | 29.11% | -54.24% | -0.72% | |
| Net Profit | -0.34 | -24.83 | 0.02 | 0.16 | 0.86 | 0.02 | 0.03 | 4.07 | 5.20 | 5.26 | 12.55 | -44.15 | -6.42 |
| EPS in Rs | -3.41 | 0.00 | 0.02 | 0.12 | 0.00 | 0.00 | 0.56 | 0.71 | 0.97 | 2.32 | -8.17 | -1.19 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.17% | 5.13% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7202.94% | 100.08% | 700.00% | 437.50% | -97.67% | 50.00% | 13466.67% | 27.76% | 1.15% | 138.59% | -451.79% |
| Change in YoY Net Profit Growth (%) | 0.00% | 7303.02% | 599.92% | -262.50% | -535.17% | 147.67% | 13416.67% | -13438.90% | -26.61% | 137.44% | -590.39% |
Family Care Hospitals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 60% |
| 5 Years: | -10% |
| 3 Years: | -43% |
| TTM: | -88% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 79% |
| 5 Years: | 186% |
| 3 Years: | 80% |
| TTM: | 164% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -8% |
| 3 Years: | -43% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 42% |
| 3 Years: | 41% |
| Last Year: | 85% |
Last Updated: September 5, 2025, 3:30 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 65 | 113 | 93 | 186 | 252 | 310 | 93 |
| Inventory Days | 149 | 29 | 4 | 6 | 16 | |||||||
| Days Payable | 977 | 212 | 382 | 387 | 126 | |||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 65 | -715 | -89 | -193 | -129 | 201 | 93 |
| Working Capital Days | -14,600 | -2,920 | -160 | -272 | -312 | -146 | -16 | 55 | 100 | 149 | 255 | 402 |
| ROCE % | -2,267% | -4% | 1% | 5% | 25% | 7% | 8% | 47% | 46% | 23% | 15% | 77% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -8.17 | 2.32 | 0.16 | 1.62 | 1.27 |
| Diluted EPS (Rs.) | -8.17 | 2.32 | 0.16 | 1.62 | 1.27 |
| Cash EPS (Rs.) | -7.96 | 2.59 | 1.23 | 2.07 | 1.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2.49 | 10.81 | 8.48 | 4.44 | 2.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2.49 | 10.81 | 8.48 | 4.44 | 2.83 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 |
| Revenue From Operations / Share (Rs.) | 1.46 | 7.41 | 8.76 | 13.10 | 11.01 |
| PBDIT / Share (Rs.) | 5.84 | 1.84 | 1.72 | 2.78 | 2.45 |
| PBIT / Share (Rs.) | 5.63 | 1.58 | 1.46 | 2.33 | 2.00 |
| PBT / Share (Rs.) | -8.23 | 1.50 | 1.37 | 2.20 | 1.76 |
| Net Profit / Share (Rs.) | -8.17 | 2.32 | 0.97 | 1.62 | 1.27 |
| PBDIT Margin (%) | 399.32 | 24.83 | 19.69 | 21.22 | 22.21 |
| PBIT Margin (%) | 385.07 | 21.28 | 16.71 | 17.80 | 18.20 |
| PBT Margin (%) | -562.53 | 20.32 | 15.68 | 16.79 | 15.98 |
| Net Profit Margin (%) | -558.47 | 31.36 | 11.11 | 12.35 | 11.52 |
| Return on Networth / Equity (%) | -327.98 | 21.49 | 11.47 | 36.50 | 44.90 |
| Return on Capital Employeed (%) | 219.07 | 14.21 | 14.74 | 37.71 | 42.77 |
| Return On Assets (%) | -95.77 | 17.93 | 7.07 | 13.05 | 19.99 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.04 | 0.14 | 0.47 |
| Total Debt / Equity (X) | 0.25 | 0.06 | 0.09 | 0.29 | 0.60 |
| Asset Turnover Ratio (%) | 0.13 | 0.55 | 0.82 | 1.40 | 1.89 |
| Current Ratio (X) | 1.28 | 5.51 | 2.83 | 1.59 | 2.08 |
| Quick Ratio (X) | 0.09 | 5.45 | 2.82 | 1.58 | 2.02 |
| Interest Coverage Ratio (X) | 110.60 | 25.90 | 19.15 | 20.92 | 10.01 |
| Interest Coverage Ratio (Post Tax) (X) | 107.78 | 33.71 | 11.81 | 13.18 | 6.19 |
| Enterprise Value (Cr.) | 22.55 | 23.96 | 45.75 | 67.13 | 54.81 |
| EV / Net Operating Revenue (X) | 2.85 | 0.59 | 0.96 | 1.60 | 1.55 |
| EV / EBITDA (X) | 0.71 | 2.41 | 4.91 | 7.52 | 6.98 |
| MarketCap / Net Operating Revenue (X) | 2.45 | 0.94 | 1.28 | 1.50 | 1.41 |
| Price / BV (X) | 1.44 | 0.64 | 1.33 | 4.43 | 5.48 |
| Price / Net Operating Revenue (X) | 2.45 | 0.94 | 1.28 | 1.50 | 1.41 |
| EarningsYield | -2.28 | 0.33 | 0.08 | 0.08 | 0.08 |
After reviewing the key financial ratios for Family Care Hospitals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -8.17. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -8.17, marking a decrease of 10.49.
- For Diluted EPS (Rs.), as of Mar 25, the value is -8.17. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -8.17, marking a decrease of 10.49.
- For Cash EPS (Rs.), as of Mar 25, the value is -7.96. This value is below the healthy minimum of 3. It has decreased from 2.59 (Mar 24) to -7.96, marking a decrease of 10.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2.49. It has decreased from 10.81 (Mar 24) to 2.49, marking a decrease of 8.32.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2.49. It has decreased from 10.81 (Mar 24) to 2.49, marking a decrease of 8.32.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.46. It has decreased from 7.41 (Mar 24) to 1.46, marking a decrease of 5.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.84. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 5.84, marking an increase of 4.00.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 5.63, marking an increase of 4.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -8.23. This value is below the healthy minimum of 0. It has decreased from 1.50 (Mar 24) to -8.23, marking a decrease of 9.73.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -8.17. This value is below the healthy minimum of 2. It has decreased from 2.32 (Mar 24) to -8.17, marking a decrease of 10.49.
- For PBDIT Margin (%), as of Mar 25, the value is 399.32. This value is within the healthy range. It has increased from 24.83 (Mar 24) to 399.32, marking an increase of 374.49.
- For PBIT Margin (%), as of Mar 25, the value is 385.07. This value exceeds the healthy maximum of 20. It has increased from 21.28 (Mar 24) to 385.07, marking an increase of 363.79.
- For PBT Margin (%), as of Mar 25, the value is -562.53. This value is below the healthy minimum of 10. It has decreased from 20.32 (Mar 24) to -562.53, marking a decrease of 582.85.
- For Net Profit Margin (%), as of Mar 25, the value is -558.47. This value is below the healthy minimum of 5. It has decreased from 31.36 (Mar 24) to -558.47, marking a decrease of 589.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is -327.98. This value is below the healthy minimum of 15. It has decreased from 21.49 (Mar 24) to -327.98, marking a decrease of 349.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is 219.07. This value is within the healthy range. It has increased from 14.21 (Mar 24) to 219.07, marking an increase of 204.86.
- For Return On Assets (%), as of Mar 25, the value is -95.77. This value is below the healthy minimum of 5. It has decreased from 17.93 (Mar 24) to -95.77, marking a decrease of 113.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.25, marking an increase of 0.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.13. It has decreased from 0.55 (Mar 24) to 0.13, marking a decrease of 0.42.
- For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 5.51 (Mar 24) to 1.28, marking a decrease of 4.23.
- For Quick Ratio (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 1. It has decreased from 5.45 (Mar 24) to 0.09, marking a decrease of 5.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 110.60. This value is within the healthy range. It has increased from 25.90 (Mar 24) to 110.60, marking an increase of 84.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 107.78. This value is within the healthy range. It has increased from 33.71 (Mar 24) to 107.78, marking an increase of 74.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 22.55. It has decreased from 23.96 (Mar 24) to 22.55, marking a decrease of 1.41.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has increased from 0.59 (Mar 24) to 2.85, marking an increase of 2.26.
- For EV / EBITDA (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to 0.71, marking a decrease of 1.70.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.45. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 2.45, marking an increase of 1.51.
- For Price / BV (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 0.64 (Mar 24) to 1.44, marking an increase of 0.80.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.45. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 2.45, marking an increase of 1.51.
- For EarningsYield, as of Mar 25, the value is -2.28. This value is below the healthy minimum of 5. It has decreased from 0.33 (Mar 24) to -2.28, marking a decrease of 2.61.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Family Care Hospitals Ltd:
- Net Profit Margin: -558.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 219.07% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -327.98% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 107.78
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.09
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 102.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -558.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | A-357, Road No.26, Wagle Industrial Estate, Thane Maharashtra 400604 | cs@scandent.in http://www.scandent.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Suchit Raghunath Modshing | Whole Time Director |
| Mr. Dhanajay Parikh | Ind. Non-Executive Director |
| Ms. Lucy Massey | Non Exe.Non Ind.Director |
| Mr. Sanjeev Seth | Ind. Non-Executive Director |
| Mrs. Archana Chirawawala | Ind. Non-Executive Director |
| Mr. Nitesh Singh | Ind. Non-Executive Director |